In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Phibro Animal Health trades 11.6% above its fair value of $32.52, driven by bullish P/E and analyst targets contrasting sharply with negative DCF results. Strong liquidity and profitability coexist with weak leverage and growth, implying financial stability but limited expansion. Monte Carlo analysis shows minimal downside risk, indicating price resilience despite valuation concerns.